J4M-20359-25951
4 vaccinations
3 coded responses
46 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 201 / VA
- Registered
- 2021-11-08
- Relationship
- Child or adolescent in my care
- Guardian
- 529-14836-28049
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-11-08
Registered in v-safe
-
2021-11-08
Dose 1 — Pfizer-BioNTech
-
2021-11-08
Health check-in — day 0, dose 1, dependentFeeling: Fair · Site: Pain, Redness · Fever · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-09
Survey response — days 1–6 daily, dose 1, dependentMedDRA: Decreased appetite — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesFree text: Loss of appetiteMedDRA releases: 2024-11 · check-in free text available
-
2021-11-11
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2021-11-12
- 2021-11-13
- 2021-11-14
- 2021-11-15
- 2021-11-22
-
2021-11-29
Dose 2 — Pfizer-BioNTech
- 2021-11-29
-
2021-11-30
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-12-01
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain, Redness · NoneAdult check-in
-
2021-12-02
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Injection site erythema, Injection site induration, Injection site mass — Feeling: Good · Site: RednessFree text: Hard lump at injection site where its redMedDRA releases: 2024-11 · check-in free text available
-
2021-12-03
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Injection site induration, Injection site swelling — Feeling: Good · Site: RednessFree text: Hard bump at injection siteMedDRA releases: 2024-11 · check-in free text available
- 2021-12-04
- 2021-12-05
- 2021-12-06
- 2021-12-13
- 2021-12-20
- 2021-12-27
- 2022-01-03
- 2022-01-10
- 2022-02-28
- 2022-05-30
-
2022-06-11
Dose 3 — Pfizer-BioNTech
-
2022-06-13
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Good · Site: Redness, Swelling · NoneAdult check-in
-
2022-06-14
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Good · Site: Redness, Swelling · NoneAdult check-in
-
2022-06-15
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Good · Site: Redness · NoneAdult check-in
- 2022-06-16
- 2022-06-20
- 2022-06-25
- 2022-07-02
- 2022-07-11
- 2022-07-17
- 2022-07-23
- 2022-09-10
-
2022-12-29
Dose 4 — Pfizer-BioNTech
-
2022-12-31
Health check-in — days 1–6 daily, dose 4, dependentFeeling: Good · Site: Redness, Swelling · NoneAdult check-in
-
2023-01-01
Health check-in — days 1–6 daily, dose 4, dependentFeeling: Good · Site: Redness · NoneAdult check-in
-
2023-01-02
Health check-in — days 1–6 daily, dose 4, dependentFeeling: Good · Site: Redness · NoneAdult check-in
- 2023-01-04
- 2023-01-05
- 2023-01-14
- 2023-01-19
- 2023-01-28
- 2023-02-02
- 2023-02-09
- 2023-03-30
- 2023-06-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-08 | Pfizer-BioNTech | No |
| 2 | 2021-11-29 | Pfizer-BioNTech | No |
| 3 | 2022-06-11 | Pfizer-BioNTech | No |
| 4 | 2022-12-29 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 1, dependent
Systemic reaction (other): Loss of appetite
Release 10 — days 1–6 daily, dose 2, dependent
Systemic reaction (other): Hard lump at injection site where its red
Systemic reaction (other): Hard bump at injection site
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Decreased appetite | · | · | ✓ |
| SRO | Injection site erythema | · | · | ✓ |
| SRO | Injection site induration | · | · | ✓ |
| SRO | Injection site mass | · | · | ✓ |
| SRO | Injection site swelling | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release